The global injectable anesthetics market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The rise in the incidence of chronic respiratory diseases such as COPD in geriatric population is one of the major factors driving the growth of the global injectable anesthetic market. For instance, according to the American Society of Anesthesiologists, growing age is anticipated to bring various health problems that might require surgery for better recovery. In addition 1 in 10 people who have surgery are 65 years or older. Also, according to the data published by World Health Organization in 2021, the share of the population aged 60 years is anticipated to increase from 1 billion in 2020 to 1.4 billion and by 2050 the world’s population of people aged 60 and older is anticipated to double to 2.1 billion.
Moreover, the number of persons aged 80 years and older are anticipated to triple between 2020 to 2050 to reach 426 million. Moreover, according to the data published by World Health Organization (WHO) in 2021, chronic obstructive pulmonary disorder is the third leading cause of death globally, causing 3.2 million deaths in 2019. Also according to the same source, asthma affected approximately 262 million people in 2019 and caused 461000 deaths. Thus, the rise in the incidence of chronic respiratory diseases is anticipated to accelerate the number of surgical procedures, which in turn will drive the growth of the global injectable anesthetics market.
Looking towards the demand for injectable anesthetics, key market players are adopting various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2020, Medovate had partnered with the New York School of Regional Anesthesia (NYSORA) to launch SAFIRA. Safira (Safer injection for regional anesthesia) is an FDA-approved technology that possesses the potential to transform anesthesia into one person procedure by enabling the control in the hands of the anesthesiologist. This technology was developed in collaboration with anesthesiologists in the UK National Health Services (NHS).
In January 2019, Dr.Reddys Laboratories Ltd. had launched Propofol Injectable Emulsion in the US market. Propofol is a therapeutic equivalent generic version of Diprivan, an injectable emulsion, approved by USFDA. Further, Propofol is available in 10ml vials for single patient use. Thus, such launches are anticipated to drive the growth of the market globally.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Injectable Anesthetics Market at https://orionmarketreports.com/request-sample/?id=95099&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Drug Class Type
- By Application
- By End-User
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Pfizer Inc, Novartis International AG, and Boehringer Ingelheim International GmbH among others
A full report is available at: https://orionmarketreports.com/global-injectable-anesthetics-market/95099/
Global Injectable Anesthetics Market Report by Segment
By Type
Local Anesthetics
General Anesthetics
By Application
- Plastic Surgeries
- Dental Surgeries
- General Surgeries
- Cosmetic Surgeries
- Gynecologic Surgeries
- Others
By End-User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
